SCHEMBL5585779

SCHEMBL5585779

COc1ccc(C(=O)C=CC(=O)Nc2ccccc2)cc1Cl

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.63
HTT P42858 2/20 0.63
KMT2A Q03164 7/20 0.55
MEN1 O00255 6/20 0.55
SMN1; SMN2 Q16637 4/20 0.55
NPC1 O15118 3/20 0.55
RAB9A P51151 3/20 0.55
STAT1 P42224 1/20 0.55
MAPT P10636 4/20 0.52
KCNH2 Q12809 1/20 0.52
HPGD P15428 2/20 0.51
TP53 P04637 1/20 0.51
PKM P14618 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
ABCG2 Q9UNQ0 1/20 0.51
LMNA P02545 2/20 0.51
KDM1A O60341 1/20 0.50
KDM4E B2RXH2 3/20 0.49
THRB P10828 1/20 0.49
POLB P06746 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5585775 1.00 ALDH1A1 (0.63) ALDH1A1HTTKMT2AMEN1SMN1; SMN2
SCHEMBL5585922 0.88 MEN1 (0.66) ALDH1A1KMT2AMEN1SMN1; SMN2NPC1
SCHEMBL5585927 0.88 MEN1 (0.66) ALDH1A1KMT2AMEN1SMN1; SMN2NPC1
SCHEMBL5585485 0.85 ABCG2 (0.59) ALDH1A1HTTKMT2AMEN1SMN1; SMN2
SCHEMBL5585475 0.85 ABCG2 (0.59) ALDH1A1HTTKMT2AMEN1SMN1; SMN2
SCHEMBL19074825 0.81 NPC1 (0.74) ALDH1A1HTTKMT2AMEN1SMN1; SMN2
SCHEMBL5585484 0.81 ALDH1A1 (0.59) ALDH1A1HTTKMT2AMEN1NPC1
SCHEMBL5585477 0.81 ALDH1A1 (0.59) ALDH1A1HTTKMT2AMEN1NPC1
Hydrochloric Acid SCHEMBL9639136 0.80 NPC1 (0.72) ALDH1A1HTTKMT2AMEN1SMN1; SMN2
SCHEMBL5585538 0.77 ABCG2 (0.56) ALDH1A1KMT2AMEN1NPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7161022-B2 Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative FUJIFILM FINECHEMICALS CO., LTD. (JP) 2007-01-09 US disclosed
US-20050176994-A1 Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative SANKIO CHEMICAL CO., LTD. (JP) 2005-08-11 US disclosed
EP-1505054-A1 PROCESS FOR PRODUCING 4-PHENYL-4-OXO-2-BUTENOIC ESTER DERIVATIVE Sankio Chemical Co., Ltd. (JP) 2005-02-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050176994-A1 Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative HPD, PAH, CYP4A11 ALDH1A1 1038/4885HTT 2460/4885KMT2A 1717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.